Skip to main content

Table 1 NEI-VFQ and SF-36 results of first stroke patients with VFD compared with healthy age- and sex-matched controls

From: Vision-related quality of life in first stroke patients with homonymous visual field defects

 

First Stroke Patients

Healthy Controls1,2

Mean difference between samples

Z1 (P)

 

M

SD

M

SD

  

NEI-VFQ (N)

      

NEI-VFQ composite score (177)

63.98

16.89

92.06

4.73

-28.08

-10.54 ‡

1. General health (173)

49.14

19.9

63.93

11.89

-14.79

-7.04 ‡

2. General vision (173)

57.23

17.88

78.72

8.39

-21.49

-10.48 ‡

3. Ocular pain (175)

86.86

16.04

86.19

7.21

0.67

1.34 (n.s.)

4. Near vision (177)

65.25

22.69

89.17

9.38

-23.92

-10.17 ‡

5. Distance vision (177)

72.75

21.31

91.12

8.94

-18.37

-8.82 ‡

6. Social functioning (177)

74.65

23.33

93.62

7.77

-18.97

-8.83 ‡

7. Mental health (174)

59.43

24.19

86.17

11.65

-27.28

-9.64 ‡

8. Role difficulties (175)

51.87

22.59

90.01

5.26

-38.14

-11.34 ‡

9. Dependency (173)

67.21

30.47

93.78

7.51

-26.57

-8.61 ‡

10. Driving (153)

27.35

33.89

88.30

8.02

-60.95

-9.43 ‡

11. Color vision (172)

86.92

22.69

94.26

6.54

-7.34

-3.35 ‡

12. Peripheral vision (175)

49.29

24.19

92.06

8.21

-42.77

-11.03 ‡

SF-36 (N)

      

1. Physical functioning (173)

66.41

27.10

80.53

10.06

-14.12

-4.96 ‡

2. Role limitations (physical) (174)

47.99

43.30

78.82

8.79

-30.81

-7.21 ‡

3. Bodily pain (174)

81.06

24.76

74.79

6.42

6.27

3.41 ‡

4. General health perceptions (173)

56.37

21.13

62.61

6.02

-6.24

-3.34 ‡

5. Vitality (176)

53.25

19.88

62.03

3.65

-8.78

-5.14 ‡

6. Social functioning (176)

74.79

26.34

87.56

2.66

-12.77

-5.01 ‡

7. Role limitations (emotional) (170)

71.76

42.75

89.21

2.78

-17.45

-1.29 (n.s.)

8. Emotional well-being (176)

66.64

18.91

74.67

2.71

-8.03

-4.54 ‡

  1. * P < 0.05; † P < 0.01; ‡ P < 0.001; 1 NEI-VFQ reference values [29]. SF-36 reference values [30]. α-adjusted significance-level is 0.00417 for NEI-VFQ and 0.00625 for SF-36. Healthy controls were matched by sex and age.